reported that CAMK4 inhibition decreased glycolysis in naïve CD4+ T cells from mice with systemic lupus erythematosus (Koga et al. 2019), and its enhanced expression promoted glucose uptake in muscle of mice (Lee et al. 2014). This evidence concerns the gene CD4 and systemic lupus erythematosus.